This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.
This is a multi-site open-label single dose gluten challenge study. Participants will provide a blood sample for measurement of cytokines before and 4 hours after eating gluten powder.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
400
Single oral dose of gluten powder
Children's Hospital Colorado
Aurora, Colorado, United States
RECRUITINGBoston Children's Hospital
Boston, Massachusetts, United States
RECRUITINGChange in serum interleukin-2 (IL-2) level from baseline to 4 hours after a single oral dose of gluten
To determine the change in serum IL-2 level from baseline after a single oral dose of gluten
Time frame: Baseline, 4 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.